Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Amgen and Carmot Therapeutics identify USP30 inhibitors

Feb. 28, 2020

Microglial fresh start helps heal brain trauma

Feb. 28, 2020

Neuronal necrosis induced by YAP deprivation mostly occurs in early stages of Alzheimer's disease

Feb. 28, 2020

Conserved epigenetic regulators prevent healthy aging

Feb. 27, 2020

ProMIS announces pilot longitudinal study to assess blood-based biomarkers for Alzheimer's

Feb. 26, 2020

Structure-based screening unveils new melatonin receptor ligands that modulate circadian rhythms

Feb. 26, 2020

Optimization and in vivo testing of bumetanide derivatives for temporal lobe epilepsy

Feb. 26, 2020

Trinucleotide expansions are too much of a good thing

Feb. 26, 2020

Oligodendrocyte-neural connections not just about myelin

Feb. 26, 2020

Herantis reports topline data from phase I/II study of CDNF in Parkinson's disease

Feb. 25, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...
Genescience presents STAT6 degrader for atopic dermatitis
BioWorld Science
Genescience Pharmaceutical Co. Ltd. has presented data on a new STAT6 PROTAC degrader – GenSciP166 – which selectively targets STAT6 for proteasomal degradation....